Human low density lipoprotein-metabolism in silico: Modeling the change of lipid-composition in the lipoprotein particle
- Conditions
- healthy participants
- Registration Number
- DRKS00005144
- Lead Sponsor
- niversitätsklinikum Freiburg
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 6
Inclusion Criteria
20-55 years normolipidemic
Exclusion Criteria
use of statins,
impaired lipoprotein-metabolism
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ipid- and apolipoprotein-concentrations before and after incubation in 6 LDL-subfractions. Established methods are used.<br>Lipids:<br>triglycerides,<br>total cholesterol,<br>free cholesterol,<br>phospholipids.<br>Apolipoproteins:<br>Apolipoprotein B-100,<br>Apolipoprotein A-I,<br>Apolipoprotein A-II,<br>Apolipoprotein E,<br>Lipoprotein LP(a)
- Secondary Outcome Measures
Name Time Method ipid- and apolipoprotein-concentrations before and after incubation in VLDL, IDL and three HDL-subfractions. Established methods are used.<br>Lipids:<br>triglycerides,<br>total cholesterol,<br>free cholesterol,<br>phospholipids.<br>Apolipoproteins:<br>Apolipoprotein B-100,<br>Apolipoprotein A-I,<br>Apolipoprotein A-II,<br>Apolipoprotein E,<br>Lipoprotein LP(a)